“The Autism Sequencing Consortium: Large-Scale, High-Throughput Sequencing in Autism Spectrum Disorders”

The Autism Sequencing Consortium has published a white paper in the journal Neuron, identifying several new potential drug targets for ASD and detailing steps forward for the field of autism research. The paper was first authored by Dr. Joseph D. Buxbaum, Director of the Seaver Autism Center, and research was supported by the National Institute of Mental Health and the Seaver Foundation. The full text of the paper can be found here, and the press release issued by the Icahn School of Medicine at Mount Sinai can be found here.

To view all News and Events, click here.

This entry was posted in News. Bookmark the permalink.